Compare PBI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBI | BHVN |
|---|---|---|
| Founded | 1920 | 2013 |
| Country | United States | United States |
| Employees | 6600 | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | 2022 |
| Metric | PBI | BHVN |
|---|---|---|
| Price | $15.67 | $9.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $13.00 | ★ $29.08 |
| AVG Volume (30 Days) | ★ 3.5M | 1.6M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.95 | $7.48 |
| 52 Week High | $15.95 | $18.57 |
| Indicator | PBI | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 73.94 | 48.49 |
| Support Level | $10.96 | $9.26 |
| Resistance Level | N/A | $10.22 |
| Average True Range (ATR) | 0.57 | 0.72 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 87.95 | 37.87 |
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.